文献速递其他结缔组织病

系统性硬化症手部功能损害的临床轨迹:跨疾病亚型未满足的临床需求

Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets.
PubMed 文献 · RMD Open · 2024-01-12

在10个中心连续纳入的396例系统性硬化症患者中,201例完成24个月随访;52.2%报告手功能临床显著恶化,不可接受手功能比例从27.8%升至35.8%(p<0.001);LASSO分析识别男性、疾病亚型、雷诺现象评分、腱鞘炎和疼痛为与手部受累恶化相关的关键因素。

要点

  • 201例完成随访的系统性硬化症患者中105例(52.2%)报告手功能临床显著恶化。
  • 不可接受手功能患者比例2年内从27.8%升至35.8%(p<0.001)。
  • 男性、疾病亚型、雷诺现象评分、腱鞘炎和疼痛被识别为与手部受累恶化相关的关键因素。

核心结论

  • 尽管现有治疗,超过50%的系统性硬化症患者手功能随时间恶化。
  • 与手功能恶化相关的因素支持炎症、血管和纤维化过程共同参与手部受累,使其成为系统性硬化症的标志性临床表现。
  • 数据旨在为针对这一主要致残因素的干预研究设计提供信息。

研究设计与样本

  • 纵向、多中心、观察性系统性硬化症队列研究,从10个中心连续纳入396例患者,其中201例有完整随访数据纳入分析。
  • 手功能通过经验证的Cochin手功能量表在24个月观察期内评估。
  • 最小临床重要差异和患者可接受症状状态按此前描述的方法分析。

主要发现

  • 纳入分析的201例患者中位(IQR)疾病病程为5(2-11)年。
  • 105例(52.2%)患者报告临床显著恶化。
  • 报告不可接受手功能的患者比例2年内从27.8%升至35.8%(p<0.001)。
  • LASSO分析识别男性性别、疾病亚型、雷诺现象评分、腱鞘炎和疼痛为与手部受累恶化相关的部分关键因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hand involvement is an early manifestation of systemic sclerosis (SSc), culprit of diagnosis and classification, and recognised major driver of disability. Impairment of hand function burdens both limited and diffuse cutaneous subsets and therefore could be targeted as 'basket' endpoint in SSc. Nevertheless, its natural history in current standard of care is not well characterised, limiting the design of targeted trials. The aim of this study is to describe prevalence, natural history and clinical factors associated with hand function deterioration in a longitudinal, multicentre, observational SSc cohort. METHODS: Hand function was captured through the validated Cochin Hand Function Scale in patients consecutively enrolled in a multicentre observational study and observed over 24 months. Minimal clinically important differences and patient acceptable symptom state were analysed as previously described. RESULTS: Three hundred and ninety-six consecutive patients were enrolled from 10 centres; 201 with complete follow-up data were included in the analysis. Median (IQR) disease duration was 5 (2-11) years. One hundred and five (52.2%) patients reported clinically significant worsening. Accordingly, the proportion of patients reporting unacceptable hand function increased over 2 years from 27.8% to 35.8% (p<0.001). Least absolute shrinkage and selection operator analysis identified male gender, disease subset, Raynaud's Condition Score, tenosynovitis and pain, as some of the key factors associated with worsening hand involvement. CONCLUSIONS: Hand function deteriorates over time in more than 50% of SSc patients despite available therapies. The analysis of factors associated with hand function worsening supports the involvement of both inflammation, vascular and fibrotic processes in hand involvement, making it a hallmark clinical manifestation of SSc. Our data are poised to inform the design of intervention studies to target this major driver of disability in SSc.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. De Lorenzis E, Kakkar V, Di Donato S, et al. Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open. 2024. PMID: 38216288. doi:10.1136/rmdopen-2023-003216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。